MeSH tree: C14.907.253.092.477
The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a study from the University of Barcelona describes a new strategy based on stem cell therapy that could ...
Oct 14, 2025
0
39
A major U.K. study of more than 165,000 dementia patients has found that risperidone raises stroke risk without exception, challenging safety assumptions by leaving no "safe group."
Oct 10, 2025
0
23
Blood thinners are often prescribed to prevent life-threatening clots. One type, called direct oral anticoagulants (DOACs), is used to treat a variety of conditions that affect blood vessels, the heart and lungs. But like ...
Oct 8, 2025
0
29
DMT, or dimethyltryptamine, is a natural psychoactive molecule found in many plants and mammals. According to an article published in Science Advances, researchers from the HUN-REN BRC Institute of Biophysics and Semmelweis ...
Sep 26, 2025
0
150
Nearly two-thirds of Americans diagnosed with Alzheimer's disease are women, and they often experience faster cognitive decline than men. The reasons behind this sex gap have largely remained a mystery—until now.
Sep 22, 2025
0
126
The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than an inactive dummy drug, ...
Sep 19, 2025
0
39
When someone has a stroke—a leading worldwide cause of death and disability—time is of the essence. Almost nine out of 10 cases are ischemic strokes, caused by restricted blood flow in the brain, and the current gold-standard ...
Sep 16, 2025
0
139
With limited treatment options for stroke patients available, two UConn researchers are developing an experimental drug that is capable of protecting the brain and improving recovery after a cerebral vascular accident also ...
Sep 12, 2025
0
26
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in high-risk non-atrial fibrillation ...
Sep 3, 2025
0
9
A Win Ratio analysis confirmed the primary result of the NOAH—AFNET 6 trial and did not find an advantage of anticoagulation with edoxaban over no anticoagulation in patients with device-detected atrial fibrillation. Clinical ...
Sep 1, 2025
0
15
